Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Epilepsia. 2020 Jan 19;61(2):249–258. doi: 10.1111/epi.16427

Table 1:

Diagnostic yield of research WES across epilepsy diagnoses

Epilepsy diagnoses n P finding LP finding VUS unsolved
DEE 88 30 (34%) 9 (10%) 17 (19%) 32 (36%)
Infantile spasms 44 8 (18%) 8 (18%) 10 (23%) 18 (41%)
Ohtahara syndrome 26 12 (46%) 1 (4%) 4 (15%) 9 (35%)
DEE, other 18 10 (56%) 0 (0%) 3 (17%) 5 (28%)
FIRES 5 0 (0%) 0 (0%) 0 (0%) 5 (100%)
Rasmussen encephalitis 5 0 (0%) 0 (0%) 1 (20%) 4 (80%)
Other focal epilepsies 12 1 (8%) 3 (25%) 0 (0%) 8 (67%)
Other generalized epilepsies 14 6 (43%) 3 (21%) 1 (7%) 4 (29%)
Prolonged febrile seizures 1 0 (0%) 0 (0%) 0 (0%) 1 (100%)
Total 125 35 (28%) 16 (12%) 19 (15%) 56 (44%)

Detection rate of WES analysis according to epilepsy syndrome. DEE = developmental and epileptic encephalopathy; FIRES = Febrile Infection-Related Epilepsy Syndrome; LP = likely pathogenic; n = number of patients; P = pathogenic; VUS = variant of unknown significance; WES = whole exome sequencing.